{"name":"Hipra Scientific, S.L.U","slug":"hipra-scientific-s-l-u","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"BIMERVAX","genericName":"BIMERVAX","slug":"bimervax","indication":"Prevention of diseases caused by specific pathogens (indication details pending clinical trials)","status":"phase_2"},{"name":"COVID-19 Vaccine HIPRA","genericName":"COVID-19 Vaccine HIPRA","slug":"covid-19-vaccine-hipra","indication":"Other","status":"phase_2"},{"name":"PHH-1V","genericName":"PHH-1V","slug":"phh-1v","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"BIMERVAX","genericName":"BIMERVAX","slug":"bimervax","phase":"phase_2","mechanism":"BIMERVAX is designed to stimulate an immune response against specific pathogens or antigens.","indications":["Prevention of diseases caused by specific pathogens (indication details pending clinical trials)"],"catalyst":""},{"name":"COVID-19 Vaccine HIPRA","genericName":"COVID-19 Vaccine HIPRA","slug":"covid-19-vaccine-hipra","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"PHH-1V","genericName":"PHH-1V","slug":"phh-1v","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxQSHNudWFIYlZxaGhINDNkemRUYzRKbVYwaW1qWkhFeXFYeUVkSFFVaWI1NjNMM05oWFBSbFRodF9Gck96cms3NmJlVVVQX01KRTFnS2M4eHNON3lyT3F5TWZTT3lqNUxKYnE0NUVnUXdWM2pZV2FzTzhSRkFybWFEYjZoMXVMR1p0R3FpQ3ZzR0F2SVBkMUlrVVV2NzM2ZUJRU01kMF9pRFhZT1Y3UC04bDRsV1l3MkpYQlN3YzlvMUtIMDd4ZkxLQXFiUDJGdHZYLXRiVjJvMGVUdw?oc=5","date":"2026-04-01","type":"pipeline","source":"Barchart.com","summary":"COVID-19 Treatment Pipeline Shows Strong Momentum as 180+ Pharma Companies in the Race | DelveInsight - Barchart.com","headline":"COVID-19 Treatment Pipeline Shows Strong Momentum as 180+ Pharma Companies in the Race | DelveInsight","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_2":3},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}